Anzeige
Mehr »
Login
Donnerstag, 23.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Mit dieser Aktie könntest Du von der Cannabis-Legalisierungswelle profitieren!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QQJB | ISIN: US52886N4060 | Ticker-Symbol:
NASDAQ
22.05.24
21:59 Uhr
2,770 US-Dollar
-0,220
-7,36 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
LEXARIA BIOSCIENCE CORP Chart 1 Jahr
5-Tage-Chart
LEXARIA BIOSCIENCE CORP 5-Tage-Chart

Aktuelle News zur LEXARIA BIOSCIENCE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiLexaria Bioscience Corp.: Lexaria Receives Two New Medical-Treatment Patents in Hypertension and Epilepsy173KELOWNA, BC / ACCESSWIRE / May 21, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces two important new...
► Artikel lesen
FrLexaria Bioscience Corp.: Dosing Begins in Lexaria's Comprehensive GLP-1 Animal Study413Study WEIGHT-A24-1 will evaluate DehydraTECH-processed pure semaglutide and liraglutideWill DehydraTECH processing result in higher brain absorption of GLP-1 drugs? KELOWNA, BC / ACCESSWIRE / May 17...
► Artikel lesen
08.05.Lexaria Bioscience Corp.: Lexaria Begins Dosing of Its Second GLP-1 Human Pilot Study192KELOWNA, BC / ACCESSWIRE / May 8, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces that human pilot study...
► Artikel lesen
06.05.Lexaria Bioscience Corp.: Lexaria Announces New Research Program to Evaluate Mode of Action and Performance of DehydraTECH-GLP-1 Drugs909KELOWNA, BC / ACCESSWIRE / May 6, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces an applied research...
► Artikel lesen
30.04.Lexaria Bioscience Corp.: Lexaria to Receive $4.7 Million Gross Proceeds in Warrant Exercise and Issuance304KELOWNA, BC / ACCESSWIRE / April 30, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces it has entered...
► Artikel lesen
24.04.Lexaria Bioscience Corp. - 8-K, Current Report-
17.04.Lexaria Bioscience, Biosig Technologies, BIMI Holdings among healthcare movers1
16.04.Lexaria gets ethics board okay for oral GLP-1 study1
16.04.Lexaria Bioscience Corp.: Lexaria Receives Ethics Review Board Approval to Begin New GLP-1 Study508Human Pilot Study #2 (GLP-1-H24-2) Approved KELOWNA, BC / ACCESSWIRE / April 16, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug...
► Artikel lesen
10.04.Lexaria Bioscience Corp expected to post a loss of 13 cents a share - Earnings Preview1
09.04.Lexaria Bioscience Corp. - 10-Q, Quarterly Report1
02.04.Lexaria Bioscience Corp.: Lexaria Awarded New Patents133Lexaria receives new patents in the fields of epilepsy and anti-viral agentsKELOWNA, BC / ACCESSWIRE / April 2, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria")...
► Artikel lesen
21.03.Lexaria to Present at The LD Micro Invitational XIV231Kelowna, British Columbia--(Newsfile Corp. - March 21, 2024) - Lexaria Bioscience Corp. (NASDAQ: LEXX) (NASDAQ: LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces...
► Artikel lesen
15.03.Lexaria Bioscience Corp. - 8-K, Current Report1
14.03.Lexaria appoints Nelson Cabatuan as CFO1
14.03.Lexaria Bioscience Corp.: Lexaria Appoints Nelson Cabatuan as Chief Financial Officer343KELOWNA, BC / ACCESSWIRE / March 14, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces the appointment...
► Artikel lesen
12.03.Lexaria Bioscience files to sell 1.61M shares of common stock for holders1
12.03.Lexaria Bioscience Corp. - S-1, General form for registration of securities1
12.03.FGEN, LEXX and SGLY among mid-day movers1
07.03.Lexaria Bioscience Corp.: Lexaria Awards Contract For Next GLP-1 Human Pilot Study571First-ever dissolvable DehydraTECH-GLP-1 oral dose formulation to be testedRybelsus® semaglutide will act as the positive controlKELOWNA, BC / ACCESSWIRE / March 7, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)...
► Artikel lesen
Seite:  Weiter >>
68 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1